NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.
Industry at Large
Daiichi Sankyo Provides Support to China
Daiichi Sankyo has launched a new social contribution initiative through an international NGO, Plan Japan, in the rural areas of Yunnan Province in China. Daiichi Sankyo provides support to help improve the health of mothers and children by developing medical professionals through additional training and promoting health education. In China, the available healthcare services for mothers and children in rural and urban areas differ significantly. The demand in rural areas for better pediatric care and medical professionals with experience in the integrated management of children’s illnesses has greatly increased.
Specialty Drug Costs spur concerns
Employers are considering unconventional strategies to manage double-digit cost increases while shifting more cost to employees, according to the Midwest Business Group on Health. Although the vast majority of employers (88%) still rely on traditional plan designs, many are ready to focus on new approaches to managing specialty drug costs.
Findings of the survey:
78% of employers are strongly concerned about the increasing costs of specialty drugs and 60% are strongly concerned about the number of specialty drugs in the pipeline.
68% of employers are considering using a narrow network, while less than 10% offer one.
16% of employers carve out their specialty drug benefit, and 63% are considering this strategy.
More than half of employers are considering shifting more costs to employees with 18% already doing so. (PV)
Script Abandonment: Untangling Influences Across the Patient Journey
Sponsored by: Zitter Health Insights
Recorded: Sept. 17, 2015
Digital Best Practices for Accelerating Drug Development
Sponsored by: DocuSign
Nov. 10, 2015
Maximizing Experiential Marketing to Deliver Great Customer Experiences
Provided by: PulseCX
Axiom honored for Innovation
Axiom by ApotheCom, a Huntsworth Health company, has been named the winner in Innovation for the LTEN Excellence Awards, honoring best-in-class learning and development initiatives within the life sciences. Axiom’s client, AstraZeneca, was seeking to increase clinical proficiency for CV specialty representatives in acute coronary syndrome. Axiom and AstraZeneca worked together to create Cardiology Day, a live, national program for 800-plus learners featuring immersive learning in the science of cardiology.
Clinipace named to Inc. List
Clinipace Worldwide, a global digital CRO, has been named to Inc. Magazine’s 34th annual Inc. 500|5000 list, which represents the most comprehensive look at America’s independent entrepreneurs. Clinipace was additionally named to the Inc. 5000 Honor Roll as a six-time honoree. The company reported revenue growth of 321% from 2011 to 2014, adding 466 jobs during that time.
Parexel Sets Gold Standard
Parexel, a global biopharmaceutical services provider, has been named by the CEO Roundtable on Cancer a CEO Cancer Gold Standard employer. The accreditation recognizes the company’s commitment to the health of its employees and their families. Parexel established programs to reduce cancer risk, including participation in cancer clinical trials and supporting the needs of cancer survivors in the workplace.